Quality control for β-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain

被引:18
作者
Cantón, R
Loza, E
Conejo, MD
Baquero, F
Martínez-Martínez, L
机构
[1] Univ Hosp Ramon & Cajal, Microbiol Serv, Madrid 28034, Spain
[2] Univ Seville, Fac Med, Dept Microbiol, Seville, Spain
[3] Hosp Univ Virgen Macarena, Microbiol Serv, Seville 41009, Spain
关键词
D O I
10.1128/JCM.41.5.1912-1918.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Eighteen Enterobacteriaceae and Pseudomonas aeruginosa strains, 16 of them with well-defined beta-lactam resistance mechanisms, were sent to 52 Spanish microbiology laboratories. Interpretative categories for 8 extended-spectrum beta-lactams were collected. Participating laboratories used their own routine susceptibility testing procedures (88% automatic systems, 10% disk diffusion, and 2% agar dilution). Control results were established by two independent reference laboratories by applying the NCCLS microdilution method and interpretative criteria. Interpretative discrepancies were observed in 16% of the results (4.4% for cefepime, 3.0% for aztreonam, 2.8% for piperacillin-tazobactam, 1.7% for cefotaxime [CTX] and ceftazidime, 1.1% for ceftriaxone, 0.9% for meropenem. and 0.3% for imipenem). High consistency with reference values (<5% of major plus very major errors) was observed with (i) American Type Culture Collection quality control strains; (ii) strains with low-efficiency, mechanisms inactivating extended-spectrum beta-lactams, such as OXA-1-producing Escherichia coli or SHV-1-hyperproducing Klebsiella pneumoniae; (iii) strains with highly efficient mechanisms, such as SHV-5 porin-deficient K. pneumoniae, CTX-M-10 in Enterobacter cloacae hyperproducing AmpC, and A aeruginosa with the MexAB OprM efflux phenotype or hyperproducing AmpC. Low consistency (>30% major plus very major errors) was detected in K1-producing klebsiella oxytoca, CTX-M-9-producing E. coli, and in OprD(-) aeruginosa strains. Extended-spectrum beta-lactamase (ESBL)-producing strains accounted for 86% of very major errors. Recognition of the ESBL phenotype was particularly low in Enterobacter cloacae strains (<35%), due to the lack of NCCLS-specific rules in this genus. A K1-producing K. oxytoca was misidentified by 10% of laboratories as an ESBL producer. The use of well-defined resistant strains is useful for improving proficiency in susceptibility testing in clinical laboratories.
引用
收藏
页码:1912 / 1918
页数:7
相关论文
共 37 条
[1]   Proficiency of clinical laboratories in spain in detecting vancomycin-resistant Enterococcus spp. [J].
Alonso-Echanove, J ;
Robles, B ;
Jarvis, WR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) :2148-2152
[2]  
[Anonymous], 2000, Rev Esp Quimioter, V13, P73
[3]  
BROWN DFJ, 2000, QUALITY ASSURANCE PR, P151
[4]  
Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610
[5]  
Cantón R, 2000, J CLIN MICROBIOL, V38, P1339
[6]   Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period [J].
Cantón, R ;
Oliver, A ;
Coque, TM ;
Varela, MD ;
Pérez-Díaz, JC ;
Baquero, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1237-1243
[7]   SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae [J].
Chaves, J ;
Ladona, MG ;
Segura, C ;
Coira, A ;
Reig, R ;
Ampurdanés, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2856-2861
[8]   Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen [J].
Cormican, MG ;
Marshall, SA ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) :1880-1884
[9]  
Elder BL, 1997, CUMITECH 31 VERIFICA
[10]   Instrumentation in antimicrobial susceptibility testing [J].
Felmingham, D ;
Brown, DFJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :81-85